{"id":1415,"date":"2022-02-13T07:03:48","date_gmt":"2022-02-13T15:03:48","guid":{"rendered":"https:\/\/info.pediatricsdirectory.com\/?p=1415"},"modified":"2023-09-09T14:16:39","modified_gmt":"2023-09-09T18:16:39","slug":"1415-2","status":"publish","type":"post","link":"https:\/\/pediatricscommunity.com\/info\/1415\/","title":{"rendered":"Shiga Toxin-Producing E. Coli"},"content":{"rendered":"\n<div class=\"wp-block-columns is-layout-flex wp-container-3\">\n<div class=\"wp-block-column is-layout-flow\" style=\"flex-basis:25%\"><i class=\"fas fa-microscope clinicaltrial\"><\/i>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow\" style=\"flex-basis:75%\">\n<h4 class=\"wp-block-heading\">OPEN CLINICAL STUDY: Hyperhydration in Children With Shiga Toxin-Producing E. Coli Infection<\/h4>\n\n\n\n<p>The objective of this study is to determine if early high volume intravenous fluid administration (hyperhydration) may be effective in mitigating or preventing complications of shiga toxin-producing E. coli (STEC) infection in children and adolescents when compared with traditional approaches (conservative fluid management).<\/p>\n\n\n\n<p><strong>MORE INFO:<\/strong> <a href=\"https:\/\/beta.clinicaltrials.gov\/study\/NCT05219110\">ClinicalTrials.gov<\/a><\/p>\n<\/div>\n<\/div>\n<span class=\"tags-links\"><a href=\"https:\/\/pediatricscommunity.com\/info\/e-coli\/\" rel=\"tag\">E. coli<\/a><a href=\"https:\/\/pediatricscommunity.com\/info\/hemolytic-uremic-syndrome\/\" rel=\"tag\">hemolytic-uremic syndrome<\/a><a href=\"https:\/\/pediatricscommunity.com\/info\/hus\/\" rel=\"tag\">HUS<\/a><a href=\"https:\/\/pediatricscommunity.com\/info\/hyperhydration\/\" rel=\"tag\">hyperhydration<\/a><a href=\"https:\/\/pediatricscommunity.com\/info\/shiga-toxin\/\" rel=\"tag\">shiga toxin<\/a><\/span>","protected":false},"excerpt":{"rendered":"<p>OPEN CLINICAL STUDY: Hyperhydration in Children With Shiga Toxin-Producing E. Coli Infection The objective of this study is to determine if early high volume intravenous fluid administration (hyperhydration) may be effective in mitigating or preventing complications of shiga toxin-producing E. coli (STEC) infection in children and adolescents when compared with traditional approaches (conservative fluid management). [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false},"categories":[9,274],"tags":[939,1177,1222,1232,1874],"_links":{"self":[{"href":"https:\/\/pediatricscommunity.com\/info\/wp-json\/wp\/v2\/posts\/1415"}],"collection":[{"href":"https:\/\/pediatricscommunity.com\/info\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pediatricscommunity.com\/info\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pediatricscommunity.com\/info\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/pediatricscommunity.com\/info\/wp-json\/wp\/v2\/comments?post=1415"}],"version-history":[{"count":1,"href":"https:\/\/pediatricscommunity.com\/info\/wp-json\/wp\/v2\/posts\/1415\/revisions"}],"predecessor-version":[{"id":5877,"href":"https:\/\/pediatricscommunity.com\/info\/wp-json\/wp\/v2\/posts\/1415\/revisions\/5877"}],"wp:attachment":[{"href":"https:\/\/pediatricscommunity.com\/info\/wp-json\/wp\/v2\/media?parent=1415"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pediatricscommunity.com\/info\/wp-json\/wp\/v2\/categories?post=1415"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pediatricscommunity.com\/info\/wp-json\/wp\/v2\/tags?post=1415"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}